In contrast, ARBs would be expected to inhibit the biologic effects of angiotensin II more completely than ACE inhibitors, since they block the pathway more distally at the level of the receptor ...
Numerous clinical studies have established that angiotensin II receptor blockers are effective as antihypertensive therapy and are well tolerated. Studies demonstrate that adding an angiotensin II ...
angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-II receptor blockers (ARBs) are thought to have specific renoprotective effects in patients with diabetic and nondiabetic nephropathy.
dce.au.dk Background and aim The prognostic impact of ACE inhibitors (ACE-Is) or angiotensin receptor blockers (ARBs) on stroke mortality remains unclear. We aimed to examine whether prestroke use of ...
Inhibition of the renin–angiotensin system using either an angiotensin-converting-enzyme (ACE) inhibitor or an angiotensin-receptor blocker (ARB) effectively decreases rates of urinary protein ...
Post-transplant erythrocytosis (PTE) is a condition with elevated haematocrit (hct) in renal allograft recipients. The mainstay of treatment is ACE inhibitors (ACEi) or angiotensin II receptor ...
even when added to an ACE inhibitor (this was demonstrated in RALES). w6 The question arises, therefore, as to what the role of the newest agents available for RAAS inhibition, the angiotensin II ...
Their most common use is when an ACE inhibitor is not able to be tolerated due to cough. Angioedema is a life-threatening reaction. This is less common with angiotensin receptor blockers than with ...
Department of Medicine, Renal Division, University of Pennsylvania, Philadelphia, Pennsylvania, USA Correspondence to Dr Raymond R Townsend Department of Medicine, Renal Division, University of ...